Biogen, Inc. (BIIB)
164.42
-4.15
(-2.46%)
USD |
NASDAQ |
Jan 16, 16:00
167.60
+3.18
(+1.93%)
After-Hours: 20:00
Biogen Price: 164.42 for Jan. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1038.40 |
| AbbVie, Inc. | 214.35 |
| Stoke Therapeutics, Inc. | 28.70 |
| Alnylam Pharmaceuticals, Inc. | 359.27 |
| Insmed, Inc. | 161.42 |
Price Related Metrics
| PE Ratio | 14.99 |
| PS Ratio | 2.488 |
| Price to Book Value | 1.325 |
| Price to Free Cash Flow | 10.66 |
| Earnings Yield | 6.67% |
| Market Cap | 24.12B |
| Operating PE Ratio | 9.884 |
| Normalized PE Ratio | 13.29 |